Add Yahoo as a preferred source to see more of our stories on Google. Eledon's kidney transplant rejection drug Eledon Pharmaceuticals’ lead asset, tegoprubart, is going to late-stage trials in kidney ...

Medical scientists involved in a large international study have identified new signs of kidney transplant rejection that could lead to more precise diagnosis and treatment for transplant recipients.

In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a blood test used to ...

Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune system. However, the innate immune system—the body's first line of defense ...

If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...

Despite advances in the field of organ transplantation, long-term organ rejection that can become apparent a decade or more after a heart or lung transplant remains a common problem for patients. This ...

Liver transplants often save the lives of seriously ill patients. However, there remains a risk that the body will reject the new organ. Doctors distinguish between acute and chronic rejection. While ...

When a donor organ is given to a recipient, it’s crucial that the recipient’s immune system doesn’t attack the donated organ as a foreign invader. While organ transplantation has advanced tremendously ...

Researchers identified a natural 'brake' within the innate immune system: the inhibitory receptor Siglec-E (SigE) and its human counterparts, Siglec-7 and Siglec-9. This receptor helps prevent ...